Charlotte Harken Jensen

Filter

2022
Inhibitors for use in prevention- and/or alleviation of heart fibrosis
Andersen, D. (Opfinder) & Jensen, C. (Opfinder), 29. dec. 2022, IPC nr. A61K31/7088, A61K39/395, C07K16/22, C12N15/113, Patentnr. WO2022268644 (A1), Prioritetsdato 21. jun. 2021, Prioritetsnr. EP20210180586
Publikation: Patent
2020
DLK1 AS A PREDICTIVE MARKER FOR INSULIN RESISTANCE AND/OR TYPE 2 DIABETES AND/OR METABOLIC SYNDROME
Andersen, D. C. (Opfinder), Jensen, C. H. (Opfinder) & Sheikh, S. P. (Opfinder), 27. maj 2020, IPC nr. C12Q 1/ 6883 A I, Patentnr. EP3657176, Prioritetsdato 23. nov. 2018, Prioritetsnr. EP20180207954
Publikation: Patent
2019

Stem cells and progenitor cells bearing CD31
Sheikh, S. (Opfinder), Andersen, D. (Opfinder) & Jensen, C. (Opfinder), 10. okt. 2019, IPC nr. A61K35/16, A61K38/19, A61P15/10, Patentnr. WO2019193052 (A1), 10. okt. 2019, Prioritetsdato 4. apr. 2018, Prioritetsnr. DKPA201870194A
Publikation: Patent

Åben adgang
2004

Isolation of cells from neural cell population using antibodies to FA1/DLK1
Jensen, C. H. (Opfinder), Wahlberg, L. (Opfinder), Grønborg, M. (Opfinder) & Teisner, B. (Opfinder), 2004, Patentnr. Patent: WO03018779, 26. maj 2004
Publikation: Patent
2001

Detection and isolation of cell populations from the CNS using antibodies to FA1/dlk1
Jensen, C. H. (Opfinder), Teisner, B. (Opfinder), Wahlberg, L. W. (Opfinder) & Grønborg, M. (Opfinder), 2001, Patentnr. US patent application
Publikation: Patent

Publikationer